- Sits on a committee covering this industry▲
- Larger than this member's usual trade▲
- Filed under family▲
Loading the dossier
The Hill Wire · Member dossier
Carol D. Miller
RepublicanRepresentative · WV-1
Current term began Jan 2025
34.4 points behind the S&P 500
Copying Miller's 9 purchases from the day each became public: +10.1%. The S&P over the same days: +44.5%.
Buys only, each purchase counted equally, not what Miller earned. 18 of the 48 members with five or more priced purchases are ahead of the index. Miller is not one of them. The typical member trails it by 2.8 points.
- Disclosed trades
- 14
- 9 purchases · 5 sales · made public since January 2025
- Disclosed volume
- $210K
- midpoints of the reported ranges, not what Miller owns
- Made public
- 32 days
- Half of Miller's trades were made public within 32 days; Congress overall 28; the law allows 45.
- On time
- 71%
- 79% across Congress
Carol Miller is a U.S. representative for West Virginia's 1st congressional district and an educator and farmer
Carol Miller is an educator, farmer, and Republican politician. She served in the West Virginia House of Delegates from 2007 to 2019. She represented West Virginia's 3rd congressional district from 2019 to 2023 and has represented the 1st district since 2023.
Miller's work as an educator and farmer provides professional context in education and agriculture. Her Ways and Means assignments also cover trade and health.
educator · farmer · politician
Generated with AI, awaiting an editor · from Wikipedia · not from the filings
What the filings show
A West Virginia House Republican whose busy stock trading puts much of the disclosed money into a narrow group of names
Miller buys and sells individual company stocks at a brisk pace, with much of the disclosed money clustered in a narrow group of names. The trades are recorded almost exclusively in her own name, with no funds or options disclosed.
What to watch
- Financials and health care connect her committee responsibilities with her disclosed stock activity.
- U.S. Bancorp, Pfizer, Target and Quest Diagnostics feature prominently; changes in those names could shift the mix.
- Filings generally meet the deadline, though some arrive late; timeliness remains worth checking.
Generated with AI, awaiting an editor, from the member’s own filings · carries no figures and makes no claim about performance
Filings that stood out
this member's highest Signal Scores · of 100, how much a filing stands out, not a rating · sorted by score, never by price move
- Sits on a committee covering this industry▲
- Larger than this member's usual trade▲
- Filed under family▲
- Sits on a committee covering this industry▲
- Larger than this member's usual trade▲
- Filed under family▲
Public information from STOCK Act filings. Amounts are reported in ranges and shown as midpoints, filings arrive after the trades, and no personal profit or loss is disclosed. Not financial advice.